Hepatitis B Immunoglobulin and Lamivudine Improve Hepatitis B–Related Outcomes After Liver Transplantation: Meta-Analysis

BACKGROUND & AIMS: HBV recurrence increases morbidity and mortality in HBsAg+ patients undergoing liver transplantation. We aimed to estimate the relative efficacy of combined therapy with hepatitis B immunoglobulin (HBIG) and lamivudine (LAM) versus HBIG monotherapy for preventing HBV-related m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: LOOMBA, ROHIT, ROWLEY, AYANA K., WESLEY, ROBERT, SMITH, KAREN G., LIANG, T. JAKE, PUCINO, FRANK, CSAKO, GYORGY
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2729093/
https://ncbi.nlm.nih.gov/pubmed/18456569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2008.02.055
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars